DEF 14AThe Ballot
Seres Therapeutics, Inc. files DEF 14A
Filed Apr 30, 2018 · 8y ago · Accession 0001193125-18-143415
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Seres Therapeutics, Inc.
- Ticker
- MCRB
- CIK
- 1609809
- Form type
- DEF 14A
- Filing date
- Apr 30, 2018
- Report date
- Jun 26, 2018
- Document
- d473444ddef14a.htm
- Size
- 1.2 MB